Compare AEIS & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEIS | ICUI |
|---|---|---|
| Founded | 1981 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 3.1B |
| IPO Year | 1996 | 1995 |
| Metric | AEIS | ICUI |
|---|---|---|
| Price | $380.04 | $121.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $307.73 | $174.33 |
| AVG Volume (30 Days) | ★ 498.5K | 220.5K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.10% | N/A |
| EPS Growth | ★ 168.53 | 100.62 |
| EPS | ★ 3.84 | 0.03 |
| Revenue | $453,095,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $22.53 | N/A |
| Revenue Next Year | $13.38 | $4.46 |
| P/E Ratio | ★ $100.89 | $4,144.00 |
| Revenue Growth | ★ 38.39 | N/A |
| 52 Week Low | $92.83 | $107.02 |
| 52 Week High | $397.44 | $160.29 |
| Indicator | AEIS | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 62.06 | 38.96 |
| Support Level | $292.26 | $121.48 |
| Resistance Level | N/A | $125.00 |
| Average True Range (ATR) | 13.92 | 4.17 |
| MACD | -0.10 | 0.16 |
| Stochastic Oscillator | 63.89 | 4.14 |
Advanced Energy Industries Inc provides precision power conversion, measurement, and control solutions. The company designs, manufactures, sells, and services power electronics conversion products that transform raw electrical power into controllable, usable power for complex equipment. It operates in one reporting segment, Power Electronics Conversion Products, serving the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets. Its products include Plasma Power Products, AC-DC Power Supply Units, DC-DC Converters, High Voltage solutions, SCR Power Controllers, and Sense and Measurement solutions. The company operates in the United States, Asia, Europe, and other regions.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.